Concurrent Use of Buprenorphine, Methadone, or Naltrexone Does Not Inhibit Ketamine's Antidepressant Activity

Biol Psychiatry. 2019 Jun 15;85(12):e75-e76. doi: 10.1016/j.biopsych.2019.02.008. Epub 2019 Mar 27.

¹ Department of Psychiatry, University of California, San Francisco, California; Weill Institute for Neurosciences, University of California, San Francisco, California; Mental Health Service, San Francisco VA Health Care System, San Francisco, California. Electronic address: tobias.marton@ucsf.edu.
² Department of Psychiatry, University of California, San Francisco, California; Weill Institute for Neurosciences, University of California, San Francisco, California; Department of Epidemiology and Biostatistics, University of California, San Francisco, California; Mental Health Service, San Francisco VA Health Care System, San Francisco, California.
³ Department of Anesthesia, University of California, San Francisco, California; Anesthesia Service, San Francisco VA Health Care System, San Francisco, California.
⁴ Department of Psychiatry, University of California, San Francisco, California; Weill Institute for Neurosciences, University of California, San Francisco, California; Mental Health Service, San Francisco VA Health Care System, San Francisco, California.

No abstract available

Publication types